Consumer Vaccine Safety and Protection Act of 2023

This bill requires sponsors of emergency-use vaccines and drugs to publicly share certain safety and efficacy data within 10 days of FDA authorization. It mandates that both sponsors (e.g., pharmaceutical companies) and the Department of Health and Human Services (HHS) disclose this data on their websites, with HHS having an additional 20 days for updates. Exceptions include trade secrets and personal information. Failure to comply results in exclusion from emergency use designations and loss of eligibility for FDA funding or approvals. The law aims to increase transparency around emergency-use medical products while maintaining confidentiality protections.